BACKGROUND: Metabolic syndrome (MS) is associated with an increased risk of cardiovascular disease. However, its prevalence in inflammatory bowel disease (IBD) patients remains largely unknown. This study was planned to determine the prevalence of MS in Japanese IBD patients. METHODS: The prevalence of MS among outpatients with IBD aged 18 or older was studied using the modified National Cholesterol Education Program Adult Treatment Panel III definition. RESULTS: A total of 107 quiescent IBD patients, including 76 ulcerative colitis (UC) patients and 31 Crohn's disease (CD) patients, were studied. Sufficient data were collected from a total of 102 patients. Prevalence of MS was significantly higher in UC (23.0%) patients compared to CD patients (7.1%). MS prevalence was substantially higher among male IBD patients (21.1%) compared to female IBD patients (12.9%), particularly in patients over 30 years of age. No difference was observed in the prevalence of MS between our IBD cohort and the general population in both males and females aged 40 years and older (P = 0.707 in males, P = 0.328 in females). IBD patients with MS were also older than those without (50.2 ± 15.0 vs. 38.0 ± 11.9 years, P = 0.013). In a logistic regression analysis, age was the statistically significant predictor of MS among IBD patients. The odds ratio (95% confidence interval) was 1.064 (1.017-1.114). CONCLUSIONS: Prevalence of metabolic syndrome in our IBD patients was comparable to that of the general population. Because age was the independent risk factor for developing MS, evaluation for MS is needed for elderly IBD patients.
BACKGROUND:Metabolic syndrome (MS) is associated with an increased risk of cardiovascular disease. However, its prevalence in inflammatory bowel disease (IBD) patients remains largely unknown. This study was planned to determine the prevalence of MS in Japanese IBDpatients. METHODS: The prevalence of MS among outpatients with IBD aged 18 or older was studied using the modified National Cholesterol Education Program Adult Treatment Panel III definition. RESULTS: A total of 107 quiescent IBDpatients, including 76 ulcerative colitis (UC) patients and 31 Crohn's disease (CD) patients, were studied. Sufficient data were collected from a total of 102 patients. Prevalence of MS was significantly higher in UC (23.0%) patients compared to CDpatients (7.1%). MS prevalence was substantially higher among male IBDpatients (21.1%) compared to female IBDpatients (12.9%), particularly in patients over 30 years of age. No difference was observed in the prevalence of MS between our IBD cohort and the general population in both males and females aged 40 years and older (P = 0.707 in males, P = 0.328 in females). IBDpatients with MS were also older than those without (50.2 ± 15.0 vs. 38.0 ± 11.9 years, P = 0.013). In a logistic regression analysis, age was the statistically significant predictor of MS among IBDpatients. The odds ratio (95% confidence interval) was 1.064 (1.017-1.114). CONCLUSIONS: Prevalence of metabolic syndrome in our IBDpatients was comparable to that of the general population. Because age was the independent risk factor for developing MS, evaluation for MS is needed for elderly IBDpatients.
Authors: M E Martínez; E Giovannucci; D Spiegelman; D J Hunter; W C Willett; G A Colditz Journal: J Natl Cancer Inst Date: 1997-07-02 Impact factor: 13.506
Authors: P Desreumaux; O Ernst; K Geboes; L Gambiez; D Berrebi; H Müller-Alouf; S Hafraoui; D Emilie; N Ectors; M Peuchmaur; A Cortot; M Capron; J Auwerx; J F Colombel Journal: Gastroenterology Date: 1999-07 Impact factor: 22.682
Authors: David J Hass; Colleen M Brensinger; James D Lewis; Gary R Lichtenstein Journal: Clin Gastroenterol Hepatol Date: 2006-04 Impact factor: 11.382
Authors: Daniéla Oliveira Magro; Everton Cazzo; Paulo Gustavo Kotze; Ana Carolina Junqueira Vasques; Carlos Augusto Real Martinez; Elinton Adami Chaim; Bruno Geloneze; José Carlos Pareja; Cláudio Saddy Rodrigues Coy Journal: Obes Surg Date: 2018-02 Impact factor: 4.129
Authors: Linda A Feagins; Avegail Flores; Cristina Arriens; Christina Park; Terri Crook; Andreas Reimold; Geri Brown Journal: Eur J Gastroenterol Hepatol Date: 2015-10 Impact factor: 2.566
Authors: Che-Yung Chao; Robert Battat; Alex Al Khoury; Sophie Restellini; Giada Sebastiani; Talat Bessissow Journal: World J Gastroenterol Date: 2016-09-14 Impact factor: 5.742
Authors: Šefket Šabanović; Majnarić Trtica Ljiljana; František Babič; Michal Vadovský; Ján Paralič; Aleksandar Včev; Andreas Holzinger Journal: BMC Med Inform Decis Mak Date: 2018-04-02 Impact factor: 2.796